Key facts
as of Oct 2026- Developer of a rapid infuser device designed to help critically ill patients requiring volume resuscitation.
- 410 Medical is valued at approximately $15.1M as of Oct 2026 (last reported valuation).
- It has raised $46.3M across 5 recorded rounds; the latest was Early Stage VC ($25.7M) in Oct 2022.
- Notable investors include Duke Capital Partners, Hatteras Venture Partners, Sovereign's Capital, Catalyst by Wellstar, OSF Ventures — 20 tracked in total.
- 410 Medical has filed 7 Form Ds with the SEC since 2017, most recently Mar 2025 ($25.7M sold to 44 investors).
- Status: Privately Held (backing).
Last reported valuation
LOW confidence$15.1M
410 Medical's last reported valuation, Oct 2019. Nothing priced has surfaced since.
Free account
More of 410 Medical with a free account
- ·The complete investor list: 20 names
- ·Watch 410 Medical: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
5 roundsAbout 410 Medical
Developer of a rapid infuser device designed to help critically ill patients requiring volume resuscitation. The company's device enhances the speed and efficiency of fluid resuscitation and improves care for patients with life-threatening illnesses such as sepsis and shock, enabling healthcare providers to easily deliver blood, blood components, crystalloids, or colloid fluids.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2013
- Employees
- 38
- Website
- 410medical.com/
- Ownership
- Privately Held (backing)